#Pharmaceuticals8
Twice-yearly HIV injection rolled out in Africa
A new twice-yearly HIV prevention injection, lenacapavir, is being introduced in several African countries. Eswatini was first to start and early supplies ran low as demand grew.
Photo by Christina Victoria Craft, Unsplash
Few new antibiotics for children amid rising resistance
Global experts warn that few child-friendly antibiotics are being developed while antimicrobial resistance already causes millions of deaths. A 2026 Benchmark finds fewer drugs in company pipelines and a shortage of medicines for under-five children.
African leaders call for local funding of medical innovation
A group of African science leaders says Africa must develop and pay for its own medical innovations to improve health and rely less on uncertain international funding. They call for more national investment, reforms and stronger research systems.
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.
No more articles